SPRY2 and neoplasm: Investigating the role of the C-terminal binding protein (CtBP), a transcriptional corepressor with known oncogenic properties, in normal and neoplastic pituitary, Dorman et al. [138] identified Spry2 as a potential target of CtBP1 and hence a potential tumor suppressor involved in regulation of pituitary cell growth and apoptosis.